Stock Screener App

Frei -

Installieren

1.67

2.34% -0.04

Engene Therapeutics Inc (ENGN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Finanzdaten der Engene Therapeutics Inc-Aktie (ENGN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-07-31	2026-04-30	2026-01-31	2025-10-31	2025-07-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Expenses	6.40% 34.01	31.97	31.18	39.48	29.95
Operating Income/Loss	6.40% -34.01	-31.97	-31.18	-39.48	-29.95
Nonoperating Income/Loss	13.10% 1.513	1.741	1.433	1.104	1.195
Income/Loss From Continuing Operations Before Tax	7.52% -32.50	-30.23	-29.75	-38.38	-28.75
Income Tax Expense/Benefit	-	-	-	-0.497	0.239
Net Income/Loss	7.52% -32.50	-30.23	-29.75	-37.88	-28.99
Basic Average Shares	0.01% 69.73	69.72	67.26	0.0879	51.10
Diluted Average Shares	0.01% 69.73	69.72	67.26	0.0879	51.10
Basic Earnings Per Share	9.30% -0.47	-0.43	0.44	0.73	0.57
Diluted Earnings Per Share	9.30% -0.47	-0.43	0.44	0.73	0.57
Common Stock Dividends	-	-	-	-	-

OLMA

$6.58

4.22%

ZVRA

$9.94

3.21%

SLDB

$5.53

3.66%

AVTX

$11.27

6.16%

NVCT

$18.60

1.74%

WVE

$3.13

1.88%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters